Calpain inhibitors as potential treatment for stroke and other neurodegenerative diseases: recent trends and developments

Author： Wells G.J.   Bihovsky R.  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.8, Iss.12, 1998-12, pp. : 1707-1727

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Flavonoids in the Treatment of Alzheimer’s and Other Neurodegenerative Diseases

By  

Current Medicinal Chemistry, Vol. 25, Iss. 27, 2018-08 ,pp. : 3228-3246

Bentham Science Publishers

Access to resources Recommend Favorite

Calpain and Its Involvement in the Pathophysiology of CNS Injuries and Diseases: Therapeutic Potential of Calpain Inhibitors for Prevention of Neurodegeneration

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 3, 2003-06 ,pp. : 173-189

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments in Cholinesterases Inhibitors for Alzheimer's Disease Treatment

By  

Current Medicinal Chemistry, Vol. 14, Iss. 25, 2007-10 ,pp. : 2654-2679

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Resveratrol and its Analogues in the Treatment of Neurodegenerative Diseases: Focus on Recent Discoveries

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 7, 2011-01 ,pp. : 849-862

Bentham Science Publishers

Access to resources Recommend Favorite

Fetal Transplantation for the Treatment of Neurodegenerative Diseases: Current Status and Future Potential

By Kopyov O.V.   Jacques S.   Eagle K.S.  

CNS Drugs, Vol. 9, Iss. 2, 1998-02 ,pp. : 77-83

Adis International

Access to resources Recommend Favorite